On March 26, Galera Therapeutics Received Letter From Nasdaq Staff Indicating That Company Has Not Regained Compliance With Minimum Market Value Of Listed Securities-8K
On March 26, Galera Therapeutics Received Letter From Nasdaq Staff Indicating That Company Has Not Regained Compliance With Minimum Market Value Of Listed Securities-8K
3月26日，Galera Therapeutics收到了納斯達克工作人員的來信，信中表示該公司尚未恢復遵守上市證券的最低市值——8K
On March 26, Galera Therapeutics Received Letter From Nasdaq Staff Indicating That Company Has Not Regained Compliance With Minimum Market Value Of Listed Securities-8K
3月26日，Galera Therapeutics收到了納斯達克工作人員的來信，信中表示該公司尚未恢復遵守上市證券的最低市值——8K
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。